Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Drug Discovery And Development

Cancer Research UK launches trial to test new drug in patients with advanced cancer

A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK today.

New bladder cancer therapy to start clinical trials

An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today.

Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer

Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer.

Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies

Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic.

Cancer Research Technology pioneer fund announces investment in blood cancer drugs

The Cancer Research Technology (CRT) Pioneer Fund announced an investment to develop a promising new class of drugs for blood cancer.

CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration

Cancer Research Technology (CRT) has today received a success payment from GlaxoSmithKline resulting from its research collaboration.

CRT and SV Life Sciences form Artios Pharma to focus on DNA damage response

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.

Scientists discover drug combination slows lung cancer cell growth

Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab.

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

Cancer Research Technology Pioneer Fund boosts investment in drugs that block cancer defences

The Cancer Research Technology (CRT) Pioneer Fund has today announced its investment in research to develop new drugs.

Pages